A concurrent resolution respecting Congressional oversight and agency studies of the appropriateness of continued use of the pertussis vaccine.

Requires the appropriate congressional committees to begin oversight hearings on: (1) the safety of the use of the pertussis vaccine; (2) the activities of the Food and Drug Administration and the Centers for Disease Control respecting the use of the vaccine and the incidence of its side effects; and (3) the need for additional legislation respecting regulation of such vaccine.

Expresses the sense of Congress that the Food and Drug Administration should begin an epidemiological study, and other appropriate studies, to determine whether or not it is consistent with public health to require or to promote the continued use of pertussis vaccine.